Advertisement
Canada markets open in 7 hours 19 minutes
  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CAD/USD

    0.7316
    -0.0004 (-0.06%)
     
  • CRUDE OIL

    83.53
    +0.17 (+0.20%)
     
  • Bitcoin CAD

    91,089.87
    +12.68 (+0.01%)
     
  • CMC Crypto 200

    1,417.39
    -6.71 (-0.47%)
     
  • GOLD FUTURES

    2,342.80
    +0.70 (+0.03%)
     
  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     
  • 10-Yr Bond

    4.5980
    -0.0520 (-1.12%)
     
  • NASDAQ futures

    17,735.25
    +128.50 (+0.73%)
     
  • VOLATILITY

    15.69
    -1.25 (-7.38%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • NIKKEI 225

    38,414.44
    +862.28 (+2.30%)
     
  • CAD/EUR

    0.6836
    0.0000 (0.00%)
     

Amazon gets big price target hike, Hasbro soars on beat, $24B medical supply deal

Here’s a look at some of the stocks the Yahoo Finance team will be watching for you today.

Hasbro (HAS) tops our list. The stock soared in early trading after the toymaker delivered a beat on both its top and bottom lines for the first three months of the year. Revenue rose more than 2% thanks to strong demand for toys based on franchises such as “Nerf” and “Transformers.” This comes after disappointing quarterly results from rival Mattel (MAT) last week.

Halliburton (HAL) shares rose in early trading after the oilfield services provider reported better-than-expected earnings and revenue for the first quarter. Revenue rose about 2% from a year ago to $4.8B as it benefited from an increase in drilling activity in North America.

Another analyst is turning bullish on Amazon (AMZN). Wedbush Securities raised its price target on the stock to $1,250 a share. That’s 39% higher than Amazon’s closing price Friday. Wedbush says it expects “substantial earnings growth” at Amazon. The e-commerce giant is scheduled to report quarterly results on Thursday.

We also have a mega deal in the medical supply space. Becton Dickinson (BDX) is buying C.R. Bard (BCR) for $24 billion in cash and stock. That translates to $317 dollars a share, which is a 25% premium based on Bard’s closing price Friday. Becton Dickinson and Bard are both century-old medical device companies based in Northern New Jersey.